NASDAQ:IBBQ Invesco Nasdaq Biotechnology ETF (IBBQ) Price, Holdings, & News → “Retirement Secret” Showed 995% Gain Last Time We Shared It (From Stansberry Research) (Ad) Free IBBQ Stock Alerts $20.52 -0.26 (-1.25%) (As of 04/25/2024 ET) Add Compare Share Share Today's Range$20.36▼$20.8050-Day Range$20.28▼$22.9852-Week Range$18.18▼$23.02Volume5,267 shsAverage Volume20,243 shsMarket Capitalization$30.16 millionAssets Under Management$30.52 millionDividend Yield0.88%Net Expense Ratio0.19% Stock AnalysisStock AnalysisChartDividendHeadlinesHoldingsOptions ChainOwnershipRatingsShort InterestSocial MediaStock AnalysisChartDividendHeadlinesHoldingsOptions ChainOwnershipRatingsShort InterestSocial Media Get Invesco Nasdaq Biotechnology ETF alerts: Email Address About Invesco Nasdaq Biotechnology ETF (NASDAQ:IBBQ)The Invesco Nasdaq Biotechnology ETF (IBBQ) is an exchange-traded fund that is based on the NASDAQ / Biotechnology index, a modified market-cap-weighted index of US biotechnology and pharmaceutical companies listed on the NASDAQ. IBBQ was launched on Jun 11, 2021 and is managed by Invesco.Read More IBBQ Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart IBBQ ETF News HeadlinesApril 1, 2024 | msn.comQQQ ETF Update, 4/1/2024February 27, 2024 | markets.businessinsider.comVestmark In Partnership With Invesco On Portfolio SolutionsApril 26, 2024 | Stansberry Research (Ad)“Retirement Secret” Showed 995% Gain Last Time We Shared ItCentral Banks Buying Gold in Record Numbers Most folks have completely missed the fact that the world's Central Banks have been quietly gobbling up as much gold as they can… Stacking it in their locked vaults on pallets in record numbers.January 10, 2024 | markets.businessinsider.comAnalyst Expectations For Invesco's FutureJanuary 9, 2024 | msn.comBiotech ETFs Stage Solid Comeback at the Start of 2024December 20, 2023 | msn.comInvesco Nasdaq Biotechnology ETF declares quarterly distribution of $0.0526December 4, 2023 | msn.comInvesco Advisors completes IHIT termination and liquidationNovember 1, 2023 | investing.comSBIO ETF Stock Price HistoryApril 26, 2024 | Stansberry Research (Ad)“Retirement Secret” Showed 995% Gain Last Time We Shared ItCentral Banks Buying Gold in Record Numbers Most folks have completely missed the fact that the world's Central Banks have been quietly gobbling up as much gold as they can… Stacking it in their locked vaults on pallets in record numbers.October 23, 2023 | msn.comInvesco BulletShares 2029 Corporate Bond ETF declares monthly distribution of $0.0621See More Headlines Receive IBBQ Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Invesco Nasdaq Biotechnology ETF and its competitors with MarketBeat's FREE daily newsletter. Email Address Fund Details IssuerInvesco Fund NameInvesco Nasdaq Biotechnology ETF Tax ClassificationRegulated Investment Company Stock ExchangeNASDAQCurrent SymbolNASDAQ:IBBQ Inception Date6/11/2021 Fund ManagerPeter Hubbard, Michael Jeanette, Pratik Doshi, Tony Seisser Previous SymbolNASDAQ:IBBQ WebN/A PhoneN/AFund Focus Asset ClassEquity BenchmarkNasdaq Biotechnology Index CategorySector FocusHealth Care Development LevelDeveloped Markets RegionNorth America Number of Holdings220 Fund Statistics Assets Under Management$30.52 million Average Daily Volume$0.00 Discount/Premium0.02% Administrator, Advisor and Custodian AdministratorThe Bank of New York Mellon Corporation AdvisorInvesco Capital Management LLC CustodianThe Bank of New York Mellon Corporation DistributorInvesco Distributors, Inc Transfer AgentThe Bank of New York Mellon Corporation TrusteeN/A Lead Market MakerLatour Trading Miscellaneous Outstanding Shares1,470,000Beta0.61 Creation Unit10,000 Creation Fee$600.00 (Almost) Everything You Need To Know About The EV MarketClick the link below and we'll send you MarketBeat's guide to investing in electric vehicle technologies (EV) and which EV stocks show the most promise. Get This Free Report Ad Stansberry Research“Retirement Secret” Showed 995% Gain Last Time We Shared ItCentral Banks Buying Gold in Record Numbers Most folks have completely missed the fact that the world's Central Banks have been quietly gobbling up as much gold as they can… Stacking it in their locked vaults on pallets in record numbers.Find out why right here (and see what you can do to get in too with just a few dollars). Invesco Nasdaq Biotechnology ETF ExpensesTypeIBBQHealth Care ETFsEquity ETFsNASDAQ ETFsAll ETFsManagement Fee0.19%0.56%0.54%0.48%0.51%Other Expenses0.00%0.40%0.54%0.34%0.58%Total Expense0.19%0.72%0.70%0.58%0.70%Fee Waiver0.00%-0.53%-0.55%-0.22%-0.57%Net Expense0.19%0.60%0.60%0.54%0.58% Invesco Nasdaq Biotechnology ETF (IBBQ) Holdings & ExposureTop 10 IBBQ HoldingsAmgen(NASDAQ:AMGN)Holding Weight: 8.68%Vertex Pharmaceuticals(NASDAQ:VRTX)Holding Weight: 8.28%Regeneron Pharmaceuticals(NASDAQ:REGN)Holding Weight: 8.22%Gilead Sciences(NASDAQ:GILD)Holding Weight: 8.18%AstraZeneca(NASDAQ:AZN)Holding Weight: 4.51%Moderna(NASDAQ:MRNA)Holding Weight: 4.37%Biogen(NASDAQ:BIIB)Holding Weight: 3.19%Illumina(NASDAQ:ILMN)Holding Weight: 2.10%Alnylam Pharmaceuticals(NASDAQ:ALNY)Holding Weight: 2.05%BioMarin Pharmaceutical(NASDAQ:BMRN)Holding Weight: 1.89%IBBQ Sector ExposureIBBQ Industry ExposureFull Holdings Details Similar ETFsPrincipal Healthcare Innovators ETFNASDAQ:BTECFirst Trust Nasdaq Pharmaceuticals ETFNASDAQ:FTXHHorizon Kinetics Medical ETFNASDAQ:MEDXJPMorgan Healthcare Leaders ETFNASDAQ:JDOCProShares UltraShort Nasdaq BiotechnologyNASDAQ:BISInstitutional OwnershipEudaimonia Advisors LLCBought 70,693 shares on 4/25/2024Ownership: 4.809%Eudaimonia Partners LLCBought 41,612 shares on 4/25/2024Ownership: 2.831%View All Institutional Transactions IBBQ ETF - Frequently Asked Questions How have IBBQ shares performed in 2024? Invesco Nasdaq Biotechnology ETF's stock was trading at $21.89 on January 1st, 2024. Since then, IBBQ shares have decreased by 6.3% and is now trading at $20.52. View the best growth stocks for 2024 here. Are investors shorting Invesco Nasdaq Biotechnology ETF? Invesco Nasdaq Biotechnology ETF saw a increase in short interest in the month of April. As of April 15th, there was short interest totaling 25,700 shares, an increase of 213.4% from the March 31st total of 8,200 shares. Based on an average daily volume of 18,100 shares, the short-interest ratio is presently 1.4 days. View Invesco Nasdaq Biotechnology ETF's Short Interest. How often does Invesco Nasdaq Biotechnology ETF pay dividends? What is the dividend yield for Invesco Nasdaq Biotechnology ETF? Invesco Nasdaq Biotechnology ETF declared a quarterly dividend on Friday, March 15th. Shareholders of record on Tuesday, March 19th will be paid a dividend of $0.0435 per share on Friday, March 22nd. This represents a $0.17 annualized dividend and a dividend yield of 0.85%. The ex-dividend date of this dividend is Monday, March 18th. Read our dividend analysis for IBBQ. What does IBBQ invest in? Invesco Nasdaq Biotechnology ETF is a equity fund issued by Invesco. IBBQ focuses on health care investments and follows the Nasdaq Biotechnology Index. The fund's investments total to approximately $30.52 million assets under management. What stocks does Invesco Nasdaq Biotechnology ETF hold? IBBQ invests in 220 holdings. Some of the stocks in their portfolio include Amgen (AMGN), Vertex Pharmaceuticals (VRTX), Regeneron Pharmaceuticals (REGN), Gilead Sciences (GILD), AstraZeneca (AZN), Moderna (MRNA), Biogen (BIIB), Illumina (ILMN), Alnylam Pharmaceuticals (ALNY) and BioMarin Pharmaceutical (BMRN). What is the management fee for Invesco Nasdaq Biotechnology ETF? Invesco Nasdaq Biotechnology ETF's management fee is 0.19% and has no other recorded expenses or fee waivers. The net expense ratio for IBBQ is 0.19%. Who are Invesco Nasdaq Biotechnology ETF's major shareholders? Invesco Nasdaq Biotechnology ETF's stock is owned by a number of retail and institutional investors. Top institutional shareholders include Eudaimonia Advisors LLC (4.81%) and Eudaimonia Partners LLC (2.83%). How do I buy shares of Invesco Nasdaq Biotechnology ETF? Shares of IBBQ stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (NASDAQ:IBBQ) was last updated on 4/26/2024 by MarketBeat.com Staff From Our PartnersThe Best AI Stock to Own in the World Today is Trading for Just $25Banyan Hill PublishingConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThese AI trades triggered this morning (545% return)Prosper Trading AcademyThe A.I. story nobody is telling you (Read ASAP)TradeSmithDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsYour Money is Not SafeAmerican AlternativeFed launches fourth dollar overhaulStansberry ResearchThe only accurate crypto trading system I know …Weiss Ratings Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Invesco Nasdaq Biotechnology ETF Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.